NEW YORK (GenomeWeb) – Fluidigm and Visiopharm have signed a comarketing agreement to automate image analysis for imaging mass cytometry, the companies said today.

Under the agreement, Fluidigm and Visiopharm will copromote Visiopharm's Phenomap image-analysis software alongside Fluidigm's Hyperion imaging system, MCD Viewer software, and related Maxpar antibodies and kits.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.